Irish pharma research company APC has announced a major expansion that will see it establish a vaccine manufacturing facility at Cherrywood in south Dublin. The company says the investment will accelerate the development and manufacture of Covid vaccines and other advanced drug therapies. APC describes itself as a medicines accelerator – a company that helps other pharma groups fast-track drug development. He said the announcement further strengthened Ireland’s position “in the global value chain of vaccine development and manufacturing”. In addition to Covid-19 vaccine research and manufacture, APC is working on more than 20 medicines for other disease areas, including a variety of cancers, respiratory diseases, Alzheimer’s disease and HIV.

Source: The Irish Times June 10, 2021 09:00 UTC